
Last Posted: Jun 23, 2022
- Evinacumab: a new option in the treatment of homozygous familial hypercholesterolemia.
Pirillo Angela et al. Expert opinion on biological therapy 2022 - A scoping review of interventions increasing screening and diagnosis of familial hypercholesterolemia.
Polanski Amanda et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022 6 - Comparison of Equations for the Calculation of LDL-Cholesterol in Familial Hypercholesterolemia: Data from Iranian Registry.
Vaseghi Golnaz et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2022 50(4) 270-275 - Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting.
Sharma Sonali et al. PloS one 2022 17(6) e0269605 - Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia.
Vuorio Alpo et al. Frontiers in pharmacology 2022 13890141 - A Selective Screening Strategy Performed in Pre-School Children and Siblings to Detect Familial Hypercholesterolemia.
Thajer Alexandra et al. Children (Basel, Switzerland) 2022 9(5) - Genetic Variant ABCC1 rs45511401 Is Associated with Increased Response to Statins in Patients with Familial Hypercholesterolemia.
Dagli-Hernandez Carolina et al. Pharmaceutics 2022 14(5) - Recent Advances on Familial Hypercholesterolemia in Children and Adolescents.
Mainieri Francesca et al. Biomedicines 2022 10(5) - Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record
G Elhanan et al, Frontiers in Genetics, April 2022 - Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults.
Bellows Brandon K et al. Journal of the American Heart Association 2022 e025192
More
Search Result Summary
- CDC Information (20)
- NIH Information (2)
- CDC Publications (5)
- COVID-19 (21)
- Human Genome Epidemiologic Studies (255)
- GWAS Studies (1)
- Human Genomics Translation/Implementation Studies (445)
- Genomic Tests Evidence Synthesis (54)
- Genomic Tests Guidelines (26)
- Tier-Classified Guidelines (10)
- Non-Genomics Precision Health (3)
- Pathogen Advanced Molecular Detection (0)
- State Public Health Genomics Programs (38)
- Ethical/Legal and Social Issues (ELSI) (0)
Quick Links to Other Resources
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 27, 2022
- Content source: